University of Naples Federico II-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2020

  1. Dasatinib discontinuation in patients with chronic-phase chronic myeloid leukemia and stable deep molecular response: the DASFREE study

    Leukemia and Lymphoma, Vol. 61, Núm. 3, pp. 650-659